We provide you with 20 years of free, institutional-grade data for CMND stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of CMND. Explore the full financial landscape of CMND stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$0
| Name | Action | Shares | Avg Price | Amount | Reported Date |
|---|
The information provided in this report about CMND stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Clearmind Medicine Inc.(NASDAQ:CMND) 
Clearmind Medicine Inc., a pre-clinical pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems. It develops treatments for alcohol use disorders, including binge drinking and eating disorders, as well as depression, binge eating, psychotherapy, mental heal...
Website: https://www.clearmindmedicine.com
Founded: 2017
IPO Price: $6.50 (Nov 15, 2022)
CEO: Adi Zuloff-Shani
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends